Moore Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Moore Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-30,000	Closed	-$17.4M	–	540
2024 Q1	$17.4M	Sell	30,000 -12,500	-29%	-$7.01M	0.28%	82
2023 Q4	$22.6M	Buy	42,500 +5,500	+15%	+$2.66M	0.39%	47
2023 Q3	$18.7M	Buy	+37,000	New	+$19.7M	0.35%	56
2023 Q2	–	Sell	-15,900	Closed	-$9.16M	–	592
2023 Q1	$9.16M	Buy	+15,900	New	+$8.96M	0.19%	98
2021 Q4	–	Sell	-59,133	Closed	-$33.8M	–	860
2021 Q3	$33.8M	Buy	+59,133	New	+$32.5M	0.52%	41
2014 Q2	–	Sell	-4,989	Closed	-$600K	–	573
2014 Q1	$600K	Hold	4,989	–	–	0.01%	345
2013 Q4	$556K	Sell	4,989 -469	-9%	-$46.6K	0.01%	329
2013 Q3	$503K	Buy	+5,458	New	+$494K	0.01%	324

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Moore Capital Management's TMO Position: Q2 2024 in Review

Moore Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 30,000 shares — an estimated $17.4M sold.

Moore Capital Management first reported a position in TMO in Q3 2013 and held it in 8 quarters. The position peaked at $33.8M in Q3 2021. 2,542 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

Moore Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
Moore Capital Management sold 30,000 Thermo Fisher Scientific shares in Q2 2024, an estimated $17.4M.
Moore Capital Management first reported a position in Thermo Fisher Scientific in Q3 2013 and held it in 8 quarters.
Moore Capital Management's Thermo Fisher Scientific position peaked at $33.8M in Q3 2021.
2,542 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Moore Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.